Market Overview

Alder Biopharma (NASDAQ: ALDR)

18.87 -0.01 (-0.05%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/17/19Canaccord GenuityDowngradesHold20.0
9/17/19MizuhoReiteratesNeutral18.0
9/17/19Credit SuisseReiteratesNeutral19.0
9/17/19UBSUpgradesNeutral19.5
9/17/19Morgan StanleyUpgradesEqual-Weight18.0
9/17/19NeedhamDowngradesHold
7/10/19Credit SuisseAssumesNeutral
3/14/19Canaccord GenuityMaintainsBuy20.0
11/06/18Credit SuisseMaintainsNeutral17.0
11/06/18Wells FargoReinstatesOutperform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter